The Triglyceride-Glucose Index Predicts Coronary Artery Disease Severity and Cardiovascular Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome

<div>Comparisons of the TyG index levels in the NSTE-ACS patients with or without GMD (a), metabolic syndrome (b), multivessel disease (c), high SYNTAX score (d), high GRACE score (e), and MACE (f). Abbreviations: GMD: glucose metabolism disorder; MetS: metabolic syndrome; MACEs: major adverse cardiovascular events.</div>

Disease Markers

fig1

Figure 1

Figure 1: The Triglyceride-Glucose Index Predicts Coronary Artery Disease Severity and Cardiovascular Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome 

Figure 1 | The Triglyceride-Glucose Index Predicts Coronary Artery Disease Severity and Cardiovascular Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome 